메뉴 건너뛰기




Volumn 9, Issue 9, 2009, Pages 1113-1126

Pharmacological options for treatment of hyperandrogenic disorders

Author keywords

5 reductase inhibitors; Androgen excess; Androgen receptor antagonists; Antiandrogen therapy

Indexed keywords

10 AZASTEROID; 4 AZASTEROID; 6 AZASTEROID; 8 CHLORO 1,2,3,4,4A,5,6,10B OCTAHYDRO 4 METHYLBENZO[F]QUINOLIN 3(2H) ONE; ANDROGEN; ANDROGEN RECEPTOR; BENZO[C]QUINOLIZINONE DERIVETIVE; BICALUTAMIDE; CHLORMADINONE ACETATE; CLOMIFENE CITRATE; CYPROTERONE ACETATE; DUTASTERIDE; EPLERENONE; EPRISTERIDE; ETHINYLESTRADIOL; FINASTERIDE; FLUTAMIDE; GLITAZONE DERIVATIVE; HEXAHYDRO DERIVATIVE; METFORMIN; NILUTAMIDE; ORAL CONTRACEPTIVE AGENT; OXIDOREDUCTASE INHIBITOR; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIANDROGEN; CHOLESTENONE 5ALPHA REDUCTASE;

EID: 70349577619     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788922692     Document Type: Review
Times cited : (7)

References (101)
  • 1
    • 15444366255 scopus 로고    scopus 로고
    • Polycystic ovary syndrome
    • Ehrmann, D.A. Polycystic ovary syndrome. N. Engl. J. Med., 2005, 352, 1223-1236.
    • (2005) N. Engl. J. Med. , vol.352 , pp. 1223-1236
    • Ehrmann, D.A.1
  • 4
    • 0037205511 scopus 로고    scopus 로고
    • Hyperandrogenaemia and the ovary
    • Norman, R.J. Hyperandrogenaemia and the ovary. Mol. Cell Endocrinol., 2002, 191, 113-119.
    • (2002) Mol. Cell Endocrinol. , vol.191 , pp. 113-119
    • Norman, R.J.1
  • 5
    • 0028173882 scopus 로고
    • Steroid 5alpha-reductase: Two genes/two enzymes
    • Russell, D.W.; Wilson, J.D. Steroid 5 alpha-reductase: two genes/two enzymes. Annu. Rev. Biochem., 1994, 63, 25-61. (Pubitemid 2109098)
    • (1994) Annual Review of Biochemistry , vol.63 , pp. 25-61
    • Russell, D.W.1    Wilson, J.D.2
  • 7
    • 33845318187 scopus 로고    scopus 로고
    • Trends in the development of new drugs for treatment of benign prostatic hyperplasia
    • DOI 10.2174/092986706779010315
    • Kulig, K; Malawska, B. Trends in the development of new drugs for treatment of benign prostatic hyperplasia. Curr. Med. Chem., 2006, 13, 3395-3416. (Pubitemid 44873752)
    • (2006) Current Medicinal Chemistry , vol.13 , Issue.28 , pp. 3395-3416
    • Kulig, K.1    Malawska, B.2
  • 8
    • 0022390704 scopus 로고
    • Species differences in prostatic steroid 5α-reductases of rat, dog, and human
    • Liang, T.; Cascieri, M.A.; Cheung, A.H.; Reynolds, G.F.; Rasmusson, G.H. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human. Endocrinology 1985, 117, 571-579. (Pubitemid 15237874)
    • (1985) Endocrinology , vol.117 , Issue.2 , pp. 571-579
    • Liang, T.1    Cascieri, M.A.2    Cheung, A.H.3
  • 10
    • 34548062694 scopus 로고    scopus 로고
    • Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators
    • DOI 10.1021/jm0613976
    • Zhang, X.; Li, X.; Allan, G.F.; Sbriscia, T.; Linton, O.; Lundeen, S.G.; Sui, Z. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators. J. Med. Chem., 2007, 50, 3857-3869. (Pubitemid 47292049)
    • (2007) Journal of Medicinal Chemistry , vol.50 , Issue.16 , pp. 3857-3869
    • Zhang, X.1    Li, X.2    Allan, G.F.3    Sbriscia, T.4    Linton, O.5    Lundeen, S.G.6    Sui, Z.7
  • 11
    • 0028033594 scopus 로고
    • The length and location of CAG trinucleotide repeats in the androgen receptor Nterminal domain affect transactivation function
    • Chamberlain, N.L.; Driver, E.D.; Miesfeld, R.L. The length and location of CAG trinucleotide repeats in the androgen receptor Nterminal domain affect transactivation function. Nucleic Acids Res., 1994, 22, 3181-3186.
    • (1994) Nucleic Acids Res. , vol.22 , pp. 3181-3186
    • Chamberlain, N.L.1    Driver, E.D.2    Miesfeld, R.L.3
  • 12
    • 0028922314 scopus 로고
    • Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenetic relevance for the (CAG)n-expanded neuronopathies
    • Kazemi-Esfarjani, P.; Trifiro, M.A.; Pinsky, L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum. Mol. Genet., 1995, 4, 523-527.
    • (1995) Hum. Mol. Genet. , vol.4 , pp. 523-527
    • Kazemi-Esfarjani, P.1    Trifiro, M.A.2    Pinsky, L.3
  • 13
    • 0033978514 scopus 로고    scopus 로고
    • Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
    • Irvine R.A, Ma H, Yu M.C, Ross R.K, Stallcup M.R, Coetzee G.A. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum. Mol. Genet., 2000, 9, 267-274. (Pubitemid 30052750)
    • (2000) Human Molecular Genetics , vol.9 , Issue.2 , pp. 267-274
    • Irvine, R.A.1    Ma, H.2    Yu, M.C.3    Ross, R.K.4    Stallcup, M.R.5    Coetzee, G.A.6
  • 15
    • 0031829734 scopus 로고    scopus 로고
    • Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne
    • Sawaya, M.E.; Shalita, A.R. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J. Cutan. Med. Surg., 1998, 3, 9-15.
    • (1998) J. Cutan. Med. Surg. , vol.3 , pp. 9-15
    • Sawaya, M.E.1    Shalita, A.R.2
  • 16
    • 49649108560 scopus 로고    scopus 로고
    • Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility
    • Wu, M.H.; Chou, Y.C.; Yu, C.P.; Yang, T.; You, S.L.; Chen, C.J.; Sun, C.A. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility. Eur. J. Cancer Prev., 2008, 17, 317-322.
    • (2008) Eur. J. Cancer Prev. , vol.17 , pp. 317-322
    • Wu, M.H.1    Chou, Y.C.2    Yu, C.P.3    Yang, T.4    You, S.L.5    Chen, C.J.6    Sun, C.A.7
  • 18
    • 8344226282 scopus 로고    scopus 로고
    • Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance
    • He, B.; Gampe, R.T. Jr.; Kole, A.J.; Hnat, A.T.; Stanley, T.B.; An, G.; Stewart, E.L.; Kalman, R.I.; Minges, J.T.; Wilson, E.M. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell, 2004, 16, 425-438.
    • (2004) Mol. Cell , vol.16 , pp. 425-438
    • He, B.1    Gampe Jr., R.T.2    Kole, A.J.3    Hnat, A.T.4    Stanley, T.B.5    An, G.6    Stewart, E.L.7    Kalman, R.I.8    Minges, J.T.9    Wilson, E.M.10
  • 20
    • 0034121290 scopus 로고    scopus 로고
    • Androgen receptor antagonists (antiandrogens): Structure-activity relationships
    • Singh, S.M.;Gauthier. S; Labrie; F. Androgen receptor antagonists (antiandrogens): structure-activity relationships. Curr. Med. Chem., 2000, 7, 211-247
    • (2000) Curr. Med. Chem. , vol.7 , pp. 211-247
    • Singh, S.M.1    Gauthier, S.2    Labrie, F.3
  • 22
    • 0027161982 scopus 로고
    • 2-terminal and steroid-binding domains
    • Wong, C.I.; Zhou, Z.X.; Sar, M.; Wilson, E.M. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid- binding domains. J. Biol. Chem., 1993, 268, 19004-19012. (Pubitemid 23273853)
    • (1993) Journal of Biological Chemistry , vol.268 , Issue.25 , pp. 19004-19012
    • Wong, C.-I.1    Zhou, Z.-X.2    Sar, M.3    Wilson, E.M.4
  • 23
    • 25444496757 scopus 로고    scopus 로고
    • Chemistry and structural biology of androgen receptor
    • Gao, W.; Bohl, C.E.; Dalton, J.T. Chemistry and structural biology of androgen receptor. Chem. Rev., 2005, 105, 3352-3370.
    • (2005) Chem. Rev. , vol.105 , pp. 3352-3370
    • Gao, W.1    Bohl, C.E.2    Dalton, J.T.3
  • 25
    • 0030913442 scopus 로고    scopus 로고
    • Pharmacological options in the treatment of benign prostatic hyperplasia
    • DOI 10.1021/jm960697s
    • Kenny,B.; Ballard, S.; Blagg, J.; Fox, D. Pharmacological options in the treatment of benign prostatic hyperplasia. J. Med. Chem., 1997, 40, 1293-1315. (Pubitemid 27198078)
    • (1997) Journal of Medicinal Chemistry , vol.40 , Issue.9 , pp. 1293-1315
    • Kenny, B.1    Ballard, S.2    Blagg, J.3    Fox, D.4
  • 26
    • 0029043487 scopus 로고
    • Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism
    • Ciotta, L.; Cianci, A.; Calogero, A.E.; Palumbo, M.A.; Marletta, E.; Sciuto, A.; Palumbo, G. Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism. Fertil. Steril., 1995, 64, 299-306.
    • (1995) Fertil. Steril. , vol.64 , pp. 299-306
    • Ciotta, L.1    Cianci, A.2    Calogero, A.E.3    Palumbo, M.A.4    Marletta, E.5    Sciuto, A.6    Palumbo, G.7
  • 27
    • 0029859309 scopus 로고    scopus 로고
    • Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
    • Castello, R.; Tosi, F.; Perrone, F.; Negri, C.; Muggeo, M.; Moghetti, P. Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up. Fertil. Steril., 1996, 66, 734-740. (Pubitemid 26357573)
    • (1996) Fertility and Sterility , vol.66 , Issue.5 , pp. 734-740
    • Castello, R.1    Tosi, F.2    Perrone, F.3    Negri, C.4    Muggeo, M.5    Moghetti, P.6
  • 28
    • 42549160531 scopus 로고    scopus 로고
    • A review of hormonal therapy for female pattern (androgenic) alopecia
    • Scheinfeld, N. A review of hormonal therapy for female pattern (androgenic) alopecia. Dermatol. Online J., 2008, 14, 1. (Pubitemid 351588724)
    • (2008) Dermatology Online Journal , vol.14 , Issue.3 , pp. 1
    • Scheinfeld, N.1
  • 29
    • 37549007228 scopus 로고    scopus 로고
    • Development of liposomal systems of finasteride for topical applications: Design, characterization, and in vitro evaluation
    • Kumar, R.; Singh, B.; Bakshi, G.; Katare, O.P. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation. Pharm. Dev. Technol., 2007, 12, 591-601.
    • (2007) Pharm. Dev. Technol. , vol.12 , pp. 591-601
    • Kumar, R.1    Singh, B.2    Bakshi, G.3    Katare, O.P.4
  • 30
    • 4644366496 scopus 로고    scopus 로고
    • Dutasteride: A potent dual inhibitor of 5-alphareductase for benign prostatic hyperplasia
    • Rabasseda, X. Dutasteride: a potent dual inhibitor of 5-alphareductase for benign prostatic hyperplasia. Drugs Today (Barc.) 2004, 40, 649-661.
    • (2004) Drugs Today (Barc.) , vol.40 , pp. 649-661
    • Rabasseda, X.1
  • 31
    • 15944382337 scopus 로고    scopus 로고
    • Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5α-reductase inhibitors
    • DOI 10.2174/0929867053507306
    • Bratoeff, E.; Cabeza, M.; Ramirez, E.; Heuze, Y.; Flores, E. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors. Curr. Med. Chem. 2005, 12, 927-943. (Pubitemid 40443848)
    • (2005) Current Medicinal Chemistry , vol.12 , Issue.8 , pp. 927-943
    • Bratoeff, E.1    Cabeza, M.2    Ramirez, E.3    Heuze, Y.4    Flores, E.5
  • 34
    • 34548656290 scopus 로고    scopus 로고
    • 3,3-Diphenylpentane skeleton as a steroid skeleton substitute: Novel inhibitors of human 5α-reductase 1
    • DOI 10.1016/j.bmcl.2007.07.039, PII S0960894X07008384
    • Hosoda, S.; Hashimoto, Y. 3,3-diphenylpentane skeleton as a steroid skeleton substitute: novel inhibitors of human 5alpha-reductase 1. Bioorg. Med. Chem. Lett., 2007, 17, 5414-5418. (Pubitemid 47398943)
    • (2007) Bioorganic and Medicinal Chemistry Letters , vol.17 , Issue.19 , pp. 5414-5418
    • Hosoda, S.1    Hashimoto, Y.2
  • 35
    • 9644290864 scopus 로고    scopus 로고
    • Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5alpha-reductases 1 and 2
    • Ferrali, A.; Menchi, G.; Occhiato, E.G.; Danza, G.; Mancina, R.; Serio, M.; Guarna, A. Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5alpha-reductases 1 and 2. Bioorg. Med. Chem. Lett., 2005, 15,145-148.
    • (2005) Bioorg. Med. Chem. Lett. , vol.15 , pp. 145-148
    • Ferrali, A.1    Menchi, G.2    Occhiato, E.G.3    Danza, G.4    Mancina, R.5    Serio, M.6    Guarna, A.7
  • 38
    • 31544462627 scopus 로고    scopus 로고
    • Novel 5alpha-reductase inhibitors: Synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids
    • Salem, OI.; Frotscher, M.; Scherer, C.; Neugebauer, A.; Biemel, K.; Streiber, M.; Maas, R.; Hartmann, R.W. Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids. J. Med. Chem., 2006, 49, 748-759.
    • (2006) J. Med. Chem. , vol.49 , pp. 748-759
    • Salem, O.I.1    Frotscher, M.2    Scherer, C.3    Neugebauer, A.4    Biemel, K.5    Streiber, M.6    Maas, R.7    Hartmann, R.W.8
  • 39
    • 0036682372 scopus 로고    scopus 로고
    • Synthesis and evaluation of 2'-substituted 4-(4′-carboxy- or 4′- carboxymethylbenzylidene)-N-acylpiperidines: Highly potent and in vivo active steroid 5alpha-reductase type 2 inhibitors
    • Picard, F.; Barassin, S.; Mokhtarian, A.; Hartmann, R.W. Synthesis and evaluation of 2'-substituted 4-(4′-carboxy- or 4′- carboxymethylbenzylidene)-N-acylpiperidines: highly potent and in vivo active steroid 5alpha-reductase type 2 inhibitors. J. Med. Chem., 2002, 45, 3406-3417.
    • (2002) J. Med. Chem. , vol.45 , pp. 3406-3417
    • Picard, F.1    Barassin, S.2    Mokhtarian, A.3    Hartmann, R.W.4
  • 40
    • 0036132203 scopus 로고    scopus 로고
    • 5-Phenyl substituted 1- methyl-2-pyridones and 4'-substituted biphenyl-4-carboxylic acids. synthesis and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2
    • Picard, F.; Schulz, T.; Hartmann, R.W. 5-Phenyl substituted 1- methyl-2-pyridones and 4'-substituted biphenyl-4-carboxylic acids. synthesis and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2. Bioorg. Med. Chem., 2002, 10, 437-448.
    • (2002) Bioorg. Med. Chem. , vol.10 , pp. 437-448
    • Picard, F.1    Schulz, T.2    Hartmann, R.W.3
  • 42
  • 44
    • 0011886496 scopus 로고
    • Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism
    • Simpson, S.A.; Tait, J.F.; Wettstein, A.; Neher, R.; Von, E.J.; Reichstein, T. Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism.. Experientia, 1953, 9, 333-335.
    • (1953) Experientia , vol.9 , pp. 333-335
    • Simpson, S.A.1    Tait, J.F.2    Wettstein, A.3    Neher, R.4    Von, E.J.5    Reichstein, T.6
  • 45
    • 0000167622 scopus 로고
    • Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt
    • Kagawa, C.M.; Cella, J.A.; Van Arman, C.G. Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt. Science, 1957, 126, 1015-1016.
    • (1957) Science , vol.126 , pp. 1015-1016
    • Kagawa, C.M.1    Cella, J.A.2    Van Arman, C.G.3
  • 47
    • 0015912489 scopus 로고
    • Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program
    • Greenblatt, D.J.; Koch-Weser, J. Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program. JAMA, 1973, 225, 40-43.
    • (1973) JAMA , vol.225 , pp. 40-43
    • Greenblatt, D.J.1    Koch-Weser, J.2
  • 48
    • 0034744368 scopus 로고    scopus 로고
    • Antimineralocorticoid 11β-substituted spirolactones exhibit androgen receptor agonistic activity: A structure function study
    • Nirde, P.; Terouanne, B.; Gallais, N.; Sultan, C.; Auzou, G. Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study. Mol. Pharmacol., 2001, 59, 1307-1313. (Pubitemid 32381610)
    • (2001) Molecular Pharmacology , vol.59 , Issue.5 , pp. 1307-1313
    • Nirde, P.1    Terouanne, B.2    Gallais, N.3    Sultan, C.4    Auzou, G.5
  • 49
    • 0021909171 scopus 로고
    • The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women
    • Lobo, R.A.; Shoupe, D.; Serafini, P.; Brinton, D.; Horton, R. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil. Steril., 1985, 43, 200-205.
    • (1985) Fertil. Steril. , vol.43 , pp. 200-205
    • Lobo, R.A.1    Shoupe, D.2    Serafini, P.3    Brinton, D.4    Horton, R.5
  • 50
    • 23944505473 scopus 로고    scopus 로고
    • Spironolactone for hirsutism in polycystic ovary syndrome
    • DOI 10.1345/aph.1G025
    • Christy, N.A.; Franks, A.S.; Cross, L.B. Spironolactone for hirsutism in polycystic ovary syndrome. Ann. Pharmacother., 2005, 39, 1517-1521. (Pubitemid 41197134)
    • (2005) Annals of Pharmacotherapy , vol.39 , Issue.9 , pp. 1517-1521
    • Christy, N.A.1    Franks, A.S.2    Cross, L.B.3
  • 51
    • 0037379703 scopus 로고    scopus 로고
    • Mutation of the androgen receptor at amino acid 708 (Gly>Ala) abolishes partial agonist activity of steroidal antiandrogens
    • DOI 10.1124/mol.63.4.791
    • Terouanne, B.; Nirde, P.; Rabenoelina, F.; Bourguet, W.; Sultan, C.; Auzou, G. Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens. Mol. Pharmacol., 2003, 63, 791-798. (Pubitemid 36368985)
    • (2003) Molecular Pharmacology , vol.63 , Issue.4 , pp. 791-798
    • Terouanne, B.1    Nirde, P.2    Rabenoelina, F.3    Bourguet, W.4    Sultan, C.5    Auzou, G.6
  • 52
    • 34250365377 scopus 로고    scopus 로고
    • Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design
    • Bohl, C.E.; Wu, Z.; Miller, D.D.; Bell, C.E.; Dalton, J.T. Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design. J. Biol. Chem., 2007, 282, 13648-13655.
    • (2007) J. Biol. Chem. , vol.282 , pp. 13648-13655
    • Bohl, C.E.1    Wu, Z.2    Miller, D.D.3    Bell, C.E.4    Dalton, J.T.5
  • 53
    • 33645395548 scopus 로고    scopus 로고
    • Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actions
    • Georget, V.; Bourguet, W.; Lumbroso, S.; Makni, S.; Sultan, C.; Nicolas, J.C. Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actions. Mol. Endocrinol., 2006, 20, 724-734.
    • (2006) Mol. Endocrinol. , vol.20 , pp. 724-734
    • Georget, V.1    Bourguet, W.2    Lumbroso, S.3    Makni, S.4    Sultan, C.5    Nicolas, J.C.6
  • 56
    • 29044448524 scopus 로고    scopus 로고
    • Chlormadinone acetate (CMA) in oral contraception - A new opportunity
    • DOI 10.1080/13625180500434889
    • Bouchard, P. Chlormadinone acetate in oral contraception - a new opportunity. Eur. J. Contracept. Reprod. Health Care, 2005, 10, 7-11. (Pubitemid 41790961)
    • (2005) European Journal of Contraception and Reproductive Health Care , vol.10 , Issue.SUPPL. 1 , pp. 7-11
    • Bouchard, P.1
  • 57
    • 0019720284 scopus 로고
    • Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens
    • keling, A.E.; Furr, B.J.; Glen, A.T.; Hughes, L.R. Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens. J. Steroid Biochem., 1981, 15, 355-359.
    • (1981) J. Steroid Biochem. , vol.15 , pp. 355-359
    • Keling, A.E.1    Furr, B.J.2    Glen, A.T.3    Hughes, L.R.4
  • 59
  • 61
    • 28944433481 scopus 로고    scopus 로고
    • Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: A randomized controlled study
    • Inal, M.M.; Yildirim, Y.; Taner, C.E. Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study. Fertil. Steril., 2005, 84, 1693-1697.
    • (2005) Fertil. Steril. , vol.84 , pp. 1693-1697
    • Inal, M.M.1    Yildirim, Y.2    Taner, C.E.3
  • 62
    • 0029863959 scopus 로고    scopus 로고
    • The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: Evidence that androgens impair insulin action in women
    • DOI 10.1210/jc.81.3.952
    • Moghetti, P.; Tosi, F.; Castello, R.; Magnani, C.M.; Negri, C.; Brun, E.; Furlani, L.; Caputo, M.; Muggeo, M. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J. Clin. Endocrinol. Metab., 1996, 81, 952-960. (Pubitemid 26083953)
    • (1996) Journal of Clinical Endocrinology and Metabolism , vol.81 , Issue.3 , pp. 952-960
    • Moghetti, P.1    Tosi, F.2    Castello, R.3    Magnani, C.M.4    Negri, C.5    Brun, E.6    Furlani, L.7    Caputo, M.8    Muggeo, M.9
  • 64
    • 0031726522 scopus 로고    scopus 로고
    • The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome
    • amanti-Kandarakis, E.; Mitrakou, A.; Raptis, S.; Tolis, G.; Duleba, A.J. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 1998, 83, 2699-2705.
    • (1998) J. Clin. Endocrinol. Metab. , vol.83 , pp. 2699-2705
    • Amanti-Kandarakis, E.1    Mitrakou, A.2    Raptis, S.3    Tolis, G.4    Duleba, A.J.5
  • 65
    • 4344635558 scopus 로고    scopus 로고
    • Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome
    • DOI 10.1159/000077827
    • Vrbikova, J.; Hill, M.; Dvorakova, K.; Stanicka, S.; Vondra, K.; Starka, L. Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome. Gynecol. Obstet. Invest., 2004, 58, 36-41. (Pubitemid 39140406)
    • (2004) Gynecologic and Obstetric Investigation , vol.58 , Issue.1 , pp. 36-41
    • Vrbikova, J.1    Hill, M.2    Dvorakova, K.3    Stanicka, S.4    Vondra, K.5    Starka, L.6
  • 66
    • 0036282585 scopus 로고    scopus 로고
    • The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome
    • Ajossa, S.; Guerriero, S.; Paoletti, A.M.; Orru, M.; Melis, G.B. The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. Fertil. Steril., 2002, 77, 1136-1140.
    • (2002) Fertil. Steril. , vol.77 , pp. 1136-1140
    • Ajossa, S.1    Guerriero, S.2    Paoletti, A.M.3    Orru, M.4    Melis, G.B.5
  • 67
    • 70450158339 scopus 로고    scopus 로고
    • Fulminant Hepatic Failure due to Nilutamide Hepatotoxicity
    • E-pub
    • Merwat, S.N.; Kabbani, W.; Adler, D.G. Fulminant Hepatic Failure due to Nilutamide Hepatotoxicity. Dig. Dis. Sci., 2008. E-pub
    • (2008) Dig. Dis. Sci.
    • Merwat, S.N.1    Kabbani, W.2    Adler, D.G.3
  • 68
    • 33646889289 scopus 로고    scopus 로고
    • Bicalutamide 150mg: A review of its use in the treatment of locally advanced prostate cancer
    • Wellington, K.; Keam, S.J. Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer. Drugs, 2006, 66, 837-850.
    • (2006) Drugs , vol.66 , pp. 837-850
    • Wellington, K.1    Keam, S.J.2
  • 69
    • 0036126649 scopus 로고    scopus 로고
    • New alternative treatment in hirsutism: Bicalutamide 25 mg/day
    • Muderris, I.I.; Bayram, F.; Ozcelik, B.; Guven, M. New alternative treatment in hirsutism: bicalutamide 25 mg/day. Gynecol. Endocrinol., 2002, 16, 63-66. (Pubitemid 34235024)
    • (2002) Gynecological Endocrinology , vol.16 , Issue.1 , pp. 63-66
    • Muderris, I.I.1    Bayram, F.2    Ozcelik, B.3    Guven, M.4
  • 70
    • 11244287310 scopus 로고    scopus 로고
    • Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance
    • DOI 10.1159/000081973
    • Bahceci, M.; Tuzcu, A.; Canoruc, N.; Tuzun, Y.; Kidir, V.; Aslan, C. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance. Horm. Res., 2004, 62, 283-287. (Pubitemid 40069627)
    • (2004) Hormone Research , vol.62 , Issue.6 , pp. 283-287
    • Bahceci, M.1    Tuzcu, A.2    Canoruc, N.3    Tuzun, Y.4    Kidir, V.5    Aslan, C.6
  • 72
    • 0035938418 scopus 로고    scopus 로고
    • Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands
    • Van Dort, M.E.; Jung, Y.W. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands. Bioorg. Med. Chem. Lett., 2001, 11, 1045-1047.
    • (2001) Bioorg. Med. Chem. Lett. , vol.11 , pp. 1045-1047
    • Van Dort, M.E.1    Jung, Y.W.2
  • 73
    • 0030698791 scopus 로고    scopus 로고
    • A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone- conditioned nude mice
    • De, B.B.; Tetelin, C.; Leroy, T.; Bonfils, A.; Van, N.D. A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone- conditioned nude mice. Br. J. Dermatol., 1997, 137, 699-702.
    • (1997) Br. J. Dermatol. , vol.137 , pp. 699-702
    • De, B.B.1    Tetelin, C.2    Leroy, T.3    Bonfils, A.4    Van, N.D.5
  • 74
    • 0346725827 scopus 로고    scopus 로고
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril., 2004, 81, 19-25.
    • (2004) Fertil. Steril. , vol.81 , pp. 19-25
  • 75
    • 70450139241 scopus 로고    scopus 로고
    • The pathogenetic background of polycystic ovary syndrome
    • Reismann, P.; Racz, K. The pathogenetic background of polycystic ovary syndrome. Diabetol. Hung., 2008, 16, 6-13.
    • (2008) Diabetol. Hung. , vol.16 , pp. 6-13
    • Reismann, P.1    Racz, K.2
  • 76
    • 42449144300 scopus 로고    scopus 로고
    • Drug Insight: Insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - A reappraisal
    • DOI 10.1038/ncpendmet0787, PII NCPENDMET0787
    • Dunaif, A. Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - a reappraisal. Nat. Clin. Pract. Endocrinol. Metab., 2008, 4, 272-283. (Pubitemid 351571139)
    • (2008) Nature Clinical Practice Endocrinology and Metabolism , vol.4 , Issue.5 , pp. 272-283
    • Dunaif, A.1
  • 77
    • 0041736553 scopus 로고    scopus 로고
    • Metformin: New understandings, new uses
    • Hundal, R.S.; Inzucchi, S.E. Metformin: new understandings, new uses. Drugs, 2003, 63, 1879-1894.
    • (2003) Drugs , vol.63 , pp. 1879-1894
    • Hundal, R.S.1    Inzucchi, S.E.2
  • 80
    • 0141724824 scopus 로고    scopus 로고
    • Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome
    • CD003053
    • Lord, J.M.; Flight, I.H.; Norman, R.J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database. Syst. Rev., 2003, CD003053.
    • (2003) Cochrane Database. Syst. Rev.
    • Lord, J.M.1    Flight, I.H.2    Norman, R.J.3
  • 82
    • 33745190800 scopus 로고    scopus 로고
    • Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women
    • Ibanez, L.; de Z.F. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women. Fertil. Steril., 2006, 86(Suppl 1), S24-S25.
    • (2006) Fertil. Steril. , vol.86 , Issue.SUPPL. 1
    • Ibanez, L.1    De, Z.F.2
  • 83
    • 19244365650 scopus 로고    scopus 로고
    • Thiazolidinediones
    • Yki-Jarvinen, H. Thiazolidinediones. N. Engl. J. Med., 2004, 351, 1106-1118.
    • (2004) N. Engl. J. Med. , vol.351 , pp. 1106-1118
    • Yki-Jarvinen, H.1
  • 84
    • 58149269401 scopus 로고    scopus 로고
    • Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients
    • Palomba, S.; Falbo, A.; Orio, F.; Zullo, F. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients. Curr. Opin. Obstet. Gynecol,. 2008, 20, 364-373.
    • (2008) Curr. Opin. Obstet. Gynecol,. , vol.20 , pp. 364-373
    • Palomba, S.1    Falbo, A.2    Orio, F.3    Zullo, F.4
  • 85
    • 27744483698 scopus 로고    scopus 로고
    • Direct thiazolidinedione action in the human ovary: Insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production
    • DOI 10.1210/jc.2005-0469
    • Seto-Young, D.; Paliou, M.; Schlosser, J.; Avtanski, D.; Park, A.; Patel, P.; Holcomb, K.; Chang, P.; Poretsky, L. Direct thiazolidinedione action in the human ovary: insulin-independent and insulinsensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J. Clin. Endocrinol. Metab., 2005, 90, 6099-6105. (Pubitemid 41606531)
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , Issue.11 , pp. 6099-6105
    • Seto-Young, D.1    Paliou, M.2    Schlosser, J.3    Avtanski, D.4    Park, A.5    Patel, P.6    Holcomb, K.7    Chang, P.8    Poretsky, L.9
  • 86
    • 34248174014 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation
    • Yang, C.C.; Wang, Y.C.; Wei, S.; Lin, L.F.; Chen, C.S.; Lee, C.C.; Lin, C.C.; Chen, CS. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation. Cancer Res., 2007, 67, 3229-3238.
    • (2007) Cancer Res. , vol.67 , pp. 3229-3238
    • Yang, C.C.1    Wang, Y.C.2    Wei, S.3    Lin, L.F.4    Chen, C.S.5    Lee, C.C.6    Lin, C.C.7    Chen, C.S.8
  • 88
    • 61649105562 scopus 로고    scopus 로고
    • Steroid biosynthesis inhibitors in the therapy of hypercortisolism: Theory and Practice
    • Igaz, P.; Tömböl, Z.; Szabo, P.M.; Liko, I.; Racz, K. Steroid biosynthesis inhibitors in the therapy of hypercortisolism: Theory and Practice. Curr. Med. Chem., 2008, 15, 2734-2747
    • (2008) Curr. Med. Chem. , vol.15 , pp. 2734-2747
    • Igaz, P.1    Tömböl, Z.2    Szabo, P.M.3    Liko, I.4    Racz, K.5
  • 89
    • 0027482984 scopus 로고
    • Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis
    • Weber, M.M.; Lang, J.; Abedinpour, F.; Zeilberger, K.; Adelmann, B.; Engelhardt, D. Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis. Clin. Investig., 1993, 71, 933-938. (Pubitemid 23327482)
    • (1993) Clinical Investigator , vol.71 , Issue.11 , pp. 933-938
    • Weber, M.M.1    Lang, J.2    Abedinpour, F.3    Zeilberger, K.4    Adelmann, B.5    Engelhardt, D.6
  • 90
    • 0038778340 scopus 로고    scopus 로고
    • Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy
    • Clement, O.O.; Freeman, C.M.; Hartmann, R.W.; Handratta, V.D.; Vasaitis, T.S.; Brodie, A.M.; Njar, V.C. Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy. J. Med. Chem., 2003, 46, 2345-2351.
    • (2003) J. Med. Chem. , vol.46 , pp. 2345-2351
    • Clement, O.O.1    Freeman, C.M.2    Hartmann, R.W.3    Handratta, V.D.4    Vasaitis, T.S.5    Brodie, A.M.6    Njar, V.C.7
  • 92
    • 0023628779 scopus 로고
    • Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease
    • Steingold, K.; De, Z.D.; Cedars, M.; Meldrum, D.R.; Lu, J.K.; Judd, H.L.; Chang, R.J. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 1987, 65,773-778.
    • (1987) J. Clin. Endocrinol. Metab. , vol.65 , pp. 773-778
    • Steingold, K.1    De, Z.D.2    Cedars, M.3    Meldrum, D.R.4    Lu, J.K.5    Judd, H.L.6    Chang, R.J.7
  • 93
    • 0025863589 scopus 로고
    • Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome
    • Gonzalez, F.; Hatala, D.A.; Speroff, L. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Am. J. Obstet. Gynecol., 1991, 165, 535-545.
    • (1991) Am. J. Obstet. Gynecol. , vol.165 , pp. 535-545
    • Gonzalez, F.1    Hatala, D.A.2    Speroff, L.3
  • 94
    • 0031029834 scopus 로고    scopus 로고
    • A long-term treatment with gonadotropinreleasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome
    • Genazzani, A.D.; Petraglia, F.; Battaglia, C.; Gamba, O.; Volpe, A.; Genazzani, A.R. A long-term treatment with gonadotropinreleasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. Fertil. Steril., 1997, 67, 463-468.
    • (1997) Fertil. Steril. , vol.67 , pp. 463-468
    • Genazzani, A.D.1    Petraglia, F.2    Battaglia, C.3    Gamba, O.4    Volpe, A.5    Genazzani, A.R.6
  • 95
    • 0030028329 scopus 로고    scopus 로고
    • Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease
    • Ciotta, L.; Cianci, A.; Giuffrida, G.; Marletta, E.; Agliano, A.; Palumbo, G. Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease. Fertil. Steril., 1996, 65, 61-67.
    • (1996) Fertil. Steril. , vol.65 , pp. 61-67
    • Ciotta, L.1    Cianci, A.2    Giuffrida, G.3    Marletta, E.4    Agliano, A.5    Palumbo, G.6
  • 96
    • 33646110761 scopus 로고    scopus 로고
    • Obesity and androgens: Facts and perspectives
    • Pasquali, R. Obesity and androgens: facts and perspectives. Fertil. Steril., 2006, 85, 1319-1340.
    • (2006) Fertil. Steril. , vol.85 , pp. 1319-1340
    • Pasquali, R.1
  • 97
    • 51649107127 scopus 로고    scopus 로고
    • Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer
    • Singh, P.; Hallur, G.; Anchoori, R.K.; Bakare, O.; Kageyama, Y.; Khan, S.R.; Isaacs, J.T. Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. Prostate, 2008, 68, 1570-1581.
    • (2008) Prostate , vol.68 , pp. 1570-1581
    • Singh, P.1    Hallur, G.2    Anchoori, R.K.3    Bakare, O.4    Kageyama, Y.5    Khan, S.R.6    Isaacs, J.T.7
  • 98
    • 0025061678 scopus 로고
    • Molecular cloning and overexpression of the human FK506-binding protein FKBP
    • DOI 10.1038/346671a0
    • Standaert, R.F.; Galat, A.; Verdine, G.L.; Schreiber, S.L. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature, 1990, 346, 671-674. (Pubitemid 20266403)
    • (1990) Nature , vol.346 , Issue.6285 , pp. 671-674
    • Standaert, R.F.1    Galat, A.2    Verdine, G.L.3    Schreiber, S.L.4
  • 99
    • 0033515037 scopus 로고    scopus 로고
    • Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces
    • Briesewitz, R.; Ray, G.T.; Wandless, T.J.; Crabtree, G.R. Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 1953-1958.
    • (1999) Proc. Natl. Acad. Sci. U. S. A. , vol.96 , pp. 1953-1958
    • Briesewitz, R.1    Ray, G.T.2    Wandless, T.J.3    Crabtree, G.R.4
  • 100
    • 0032860819 scopus 로고    scopus 로고
    • Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers
    • Muthuswamy, S.K.; Gilman, M.; Brugge, J.S. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol.Cell Biol., 1999, 19, 6845-6857.
    • (1999) Mol.Cell Biol. , vol.19 , pp. 6845-6857
    • Muthuswamy, S.K.1    Gilman, M.2    Brugge, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.